Literature DB >> 11311902

Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice.

R X Moldrich1, P M Beart, D E Jane, A G Chapman, B S Meldrum.   

Abstract

The 3,4-dicarboxyphenylglycines (3,4-DCPG) inhibit sound-induced seizures in DBA/2 mice with the racemate being notably more potent than either isomer (ED(50) (nmol, i.c.v.)): (RS)-3,4-DCPG (0.004; 86 mg/kg, i.p.)>>the mGlu(8) agonist (S)-3,4-DCPG (0.11)>the AMPA antagonist (R)-3,4-DCPG (0.38). A potentiation of anticonvulsant activity between AMPA and mGlu(8) receptors was confirmed by combining (R)-3,4-DCPG with the mGlu(8) agonist (RS)-4-phosphonophenylglycine. This potentiating mechanism provides a novel strategy for the treatment of epileptic seizures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311902     DOI: 10.1016/s0028-3908(01)00002-8

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

Review 1.  Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Authors:  James N C Kew; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

Review 2.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

3.  Agonists and antagonists of metabotropic glutamate receptors: anticonvulsants and antiepileptogenic agents?

Authors:  Feng Ru Tang
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

4.  Phenylglycine derivatives as antagonists of group III metabotropic glutamate receptors expressed on neonatal rat primary afferent terminals.

Authors:  Jacqueline C Miller; Patrick A Howson; Stuart J Conway; Richard V Williams; Barry P Clark; David E Jane
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

5.  N-salicyloyltryptamine, a new anticonvulsant drug, acts on voltage-dependent Na+, Ca2+, and K+ ion channels.

Authors:  Démetrius Antonio Machado Araújo; Roberta Amaral Mafra; Andréia Laura Prates Rodrigues; Válter Miguel-Silva; Paulo Sérgio Lacerda Beirão; Reinaldo Nóbrega de Almeida; Lucindo Quintans; Maria Fátima Vanderlei de Souza; Jader Santos Cruz
Journal:  Br J Pharmacol       Date:  2003-12       Impact factor: 8.739

6.  Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.

Authors:  Helena Domin; Krystyna Gołembiowska; Danuta Jantas; Katarzyna Kamińska; Barbara Zięba; Maria Smiałowska
Journal:  Neurotox Res       Date:  2014-01-09       Impact factor: 3.911

Review 7.  The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum.

Authors:  Serena Boccella; Ida Marabese; Francesca Guida; Livio Luongo; Sabatino Maione; Enza Palazzo
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.